•
Dec 31, 2022

Nkgen Biotech Q4 2022 Earnings Report

EPS
-$0.14
Previous year: -$0.1
+40.0%
Gross Profit
-$15K
Cash and Equivalents
$117K
Previous year: $1.72M
-93.2%
Free Cash Flow
-$568K
Total Assets
$16.3M
Previous year: $174M
-90.6%

Nkgen Biotech

Nkgen Biotech